Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection
mBio · 2025
DOI: 10.1128/mbio.02088-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Hailey A Barker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Disease Susceptibility, Salmonella Infections, Receptor, Cannabinoid, CB2, Receptor, Cannabinoid, CB1. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consortium for Medical Marijuana Clinical Outcomes Research, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Host resilience to bacterial infection depends on tightly regulated immune responses, which can be shaped by metabolic cues, including the contribution from bioactive lipids. The endocannabinoid system (ECS), a lipid signaling network known for its neuromodulatory roles, also influences immunity; however, the receptor-specific contributions of cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) in host–pathogen interactions remain incompletely defined in this context. Using receptor-deficient mouse models, we investigated how CB1R and CB2R modify immune responses to Salmonella Typhimurium. CB1R-deficient (CB1R-KO) mice exhibited heightened systemic inflammation, impaired bacterial clearance, and reduced survival in systemic infection, associated with dysregulated macrophage polarization and diminished neutrophil recruitment. In contrast, CB2R-KO mice showed increased susceptibility in both systemic and mucosal infection models, marked by a pro-inflammatory macrophage profile, enhanced neutrophilia, and microbiota dysbiosis. Shotgun metagenomic analysis revealed a reduced abundance of specific protective commensals and altered microbial metabolic pathway profiles in CB2R-KO mice, suggesting a role for CB2R in maintaining mucosal immune–microbiota homeostasis. Collectively, these findings highlight non-redundant roles for CB1R and CB2R in regulating immune dynamics and salmonellosis disease severity, and they point to the ECS as a potential target for host-directed immunomodulatory therapies. IMPORTANCE Effective immunity against bacterial pathogens requires a delicate balance between microbial clearance and the containment of inflammatory damage encountered during many infections. The molecular pathways that regulate this equilibrium remain incompletely defined, and the involvement of bioactive lipid signaling mechanisms also needs to be better described. Here, we show that the endocannabinoid receptors CB1R and CB2R play non-redundant roles in host defense against Salmonella infection. CB1R deficiency results in exacerbated systemic inflammation, defective bacterial clearance, and dysregulated macrophage polarization. In contrast, CB2R deficiency leads post-infection to gut dysbiosis and has been found to negatively affect the outcome for the host in both systemic and mucosal infection with Salmonella . By describing cannabinoid receptor-specific contributions to immune regulation and microbiota dynamics, our findings reveal a previously underappreciated axis of host–pathogen interaction. This study broadens our understanding of lipid-mediated immune modulation and identifies CB1R and CB2R as potential targets for therapies aimed at restoring immune homeostasis and improving infectious disease outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Cell Science, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, Florida, USA.
- Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, São Paulo, Brazil.
ORCID-Profile: Hailey A Barker, Mariola J Ferraro
Förderung
- Consortium for Medical Marijuana Clinical Outcomes Research
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Barker, H. A., Bhimani, S., Tirado, D., Canas, J. J., Lemos, L. N., Roesch, L. F. W., & Ferraro, M. J. (2025). Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection. mBio. https://doi.org/10.1128/mbio.02088-25
Vancouver
Barker HA, Bhimani S, Tirado D, Canas JJ, Lemos LN, Roesch LFW, et al. Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection. mBio. 2025. doi:10.1128/mbio.02088-25
BibTeX
@article{Barker2025,
author = {Barker, Hailey A and Bhimani, Saloni and Tirado, Deyaneira and Canas, Jorge J and Lemos, Leandro Nascimento and Roesch, Luiz F W and Ferraro, Mariola J},
title = {Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.02088-25}
}
EUVIMED